These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3116835)

  • 21. Activated charcoal impairs propantheline absorption.
    Chaput de Saintonge DM; Herxheimer A
    Eur J Clin Pharmacol; 1971 Dec; 4(1):52-3. PubMed ID: 5151392
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of chloroquine absorption by activated charcoal.
    Neuvonen PJ; Kivistö KT; Laine K; Pyykkö K
    Hum Exp Toxicol; 1992 Mar; 11(2):117-20. PubMed ID: 1349217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of activated charcoal on the absorption of amiodarone.
    Kivistö KT; Neuvonen PJ
    Hum Exp Toxicol; 1991 Sep; 10(5):327-9. PubMed ID: 1683545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The action of activated charcoal on poisons in the digestive tract.
    Chin L; Picchioni AL; Duplisse BR
    Toxicol Appl Pharmacol; 1970 May; 16(3):786-99. PubMed ID: 5422220
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of activated charcoal on rifampicin absorption in man.
    Orisakwe OE; Dioka CE; Okpogba AN; Orish CN; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):51-4. PubMed ID: 9239805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between effect of activated charcoal on drug absorption in man and its drug adsorption characteristics in vitro.
    Tsuchiya T; Levy G
    J Pharm Sci; 1972 Apr; 61(4):586-9. PubMed ID: 5014316
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduction of absorption of paracetamol by activated charcoal and cholestyramine: a possible therapeutic measure.
    Dordoni B; Willson RA; Thompson RP; Williams R
    Br Med J; 1973 Jul; 3(5871):86-7. PubMed ID: 4717848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of activated charcoal on diethylcarbamazine absorption in humans.
    Orisakwe OE; Ilondu ND; Afonne OJ; Ofoefule SI; Orish CN; Agbasi PU
    Am J Ther; 2001; 8(1):7-9. PubMed ID: 11304652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin.
    Scheinin M; Virtanen R; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):38-42. PubMed ID: 3988390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adsorption and prevention of gastrointestinal absorption of nalidixic acid by activated carbon beads.
    Honda Y; Nakano M; Nakano NI
    Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4385-8. PubMed ID: 3829170
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide.
    Neuvonen PJ; Kivistö K; Hirvisalo EL
    Br J Clin Pharmacol; 1988 Feb; 25(2):229-33. PubMed ID: 3358884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal antidotal dose of activated charcoal.
    Chin L; Picchioni AL; Bourn WM; Laird HE
    Toxicol Appl Pharmacol; 1973 Sep; 26(1):103-8. PubMed ID: 4748129
    [No Abstract]   [Full Text] [Related]  

  • 34. Gastrointestinal clearance of drugs with activated charcoal.
    Levy G
    N Engl J Med; 1982 Sep; 307(11):676-8. PubMed ID: 7110218
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug adsorption efficacy of commercial activated charcoal tablets in vitro and in man.
    Tsuchiya T; Levy G
    J Pharm Sci; 1972 Apr; 61(4):624-5. PubMed ID: 4552282
    [No Abstract]   [Full Text] [Related]  

  • 36. Adsorbent and cathartic inhibition of enteral drug absorption.
    Van de Graaff WB; Thompson WL; Sunshine I; Fretthold D; Leickly F; Dayton H
    J Pharmacol Exp Ther; 1982 Jun; 221(3):656-63. PubMed ID: 7086679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition.
    Glazko AJ
    Ann Phys Med; 1966; Suppl():23-36. PubMed ID: 4979052
    [No Abstract]   [Full Text] [Related]  

  • 38. Activated charcoal as a gastrointestinal decontaminant: experiences with experimental animals and human subjects.
    Decker WJ; Corby DG
    Clin Toxicol; 1970 Mar; 3(1):1-4. PubMed ID: 5520389
    [No Abstract]   [Full Text] [Related]  

  • 39. [Determination of flecainide concentration in blood plasma by HPLC and pharmacokinetic parameters in volunteers].
    Li XY; He JB; Tan WP; Yu ST; Huang W; Sun JP; Yu CH; Qian F
    Yao Xue Xue Bao; 1989; 24(6):452-7. PubMed ID: 2514579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated charcoal-carboxymethylcellulose gel formulation as an antidotal agent for orally ingested aspirin.
    Mathur LK; Jaffe JM; Colaizzi JL; Moriarty RW
    Am J Hosp Pharm; 1976 Jul; 33(7):717-9. PubMed ID: 941924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.